These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20070029)

  • 41. [Relationship of interleukin-10 gene polymorphism with restenosis after percutaneous coronary intervention in Chinese].
    Gao J; Cui RZ; Liu Y; Mao YM; Zhou J; Chen Q; Zhao FM; Yang GM; Liu T
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Feb; 28(1):42-6. PubMed ID: 21287508
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic risk for restenosis after coronary balloon angioplasty.
    Horibe H; Yamada Y; Ichihara S; Watarai M; Yanase M; Takemoto K; Shimizu S; Izawa H; Takatsu F; Yokota M
    Atherosclerosis; 2004 May; 174(1):181-7. PubMed ID: 15135268
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
    Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
    Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Repeat intracoronary beta-brachytherapy using a rhenium-188-filled balloon catheter for recurrent restenosis in patients who failed intracoronary radiation therapy.
    Wöhrle J; Krause BJ; Nusser T; Kochs M; Höher M
    Cardiovasc Revasc Med; 2006; 7(1):2-6. PubMed ID: 16513516
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
    Gross CM; Perrot A; Geier C; Posch MG; Hassfeld S; Kramer J; Schmidt S; Derer W; Dietz R; Ozcelik C
    J Invasive Cardiol; 2007 Jun; 19(6):261-4. PubMed ID: 17541127
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Polymorphism K469E of intercellular adhesion molecule-1 gene and restenosis after coronary stenting in Chinese patients.
    Liu ZP; Huo Y; Li JP; Zhang Y; Xue L; Zhao CY; Hong XM; Huang AQ; Gao W
    Chin Med J (Engl); 2004 Feb; 117(2):172-5. PubMed ID: 14975197
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting.
    Maresta A; Balducelli M; Latini R; Bernardi G; Moccetti T; Sosa C; Barlera S; Varani E; Ribeiro da Silva EE; Monici Preti A; Maggioni AP;
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):375-82. PubMed ID: 15736248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Provisional stenting for multivessel PCI.
    Han B; Liu L; Aboud M; Nahir M; Hasin Y
    Int J Cardiovasc Intervent; 2005; 7(1):46-51. PubMed ID: 16019615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing.
    Stankovic G; Colombo A; Bersin R; Popma J; Sharma S; Cannon LA; Gordon P; Nukta D; Braden G; Collins M;
    Am J Cardiol; 2004 Apr; 93(8):953-8. PubMed ID: 15081434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The rs1803274 polymorphism of the BCHE gene is associated with an increased risk of coronary in-stent restenosis.
    Pleva L; Kovarova P; Faldynova L; Plevova P; Hilscherova S; Zapletalova J; Kusnierova P; Kukla P
    BMC Cardiovasc Disord; 2015 Oct; 15():135. PubMed ID: 26497592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and predictors of late total occlusion following coronary stenting.
    Shah PB; Cutlip DE; Popma JJ; Kuntz RE; Ho KK
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):344-51. PubMed ID: 14571485
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting.
    Martínez-Ríos MA; Peña-Duque MA; Fragoso JM; Delgadillo-Rodríguez H; Rodríguez-Pérez JM; Miranda-Malpica E; Cruz-Robles D; Cavazos-Quero MM; Rodríguez-Lobato LG; Vargas-Alarcón G
    Biochem Genet; 2009 Oct; 47(9-10):707-16. PubMed ID: 19585232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Are common leptin promoter polymorphisms associated with restenosis after coronary stenting?
    Bienertová-Vasků JA; Hlinomaz O; Vasků A
    Heart Vessels; 2007 Sep; 22(5):310-5. PubMed ID: 17879022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiographic and clinical outcomes of rosiglitazone in patients with type 2 diabetes mellitus after percutaneous coronary interventions: a single center experience.
    Fang CC; Ng Jao YT; Yi-Chen ; Yu CL; Chen CL; Wang SP
    Angiology; 2007; 58(5):523-34. PubMed ID: 18024934
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term clinical outcome after implantation of medium Palmaz (biliary) stents in very large native coronary arteries.
    Chio FL; Liu MW; Al-Saif SM; Khan MA; Lawson D; Al-Mubarak N
    Catheter Cardiovasc Interv; 2002 May; 56(1):35-9. PubMed ID: 11979531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catheter-based delivery of fluid paclitaxel for prevention of restenosis in native coronary artery lesions after stent implantation.
    Herdeg C; Göhring-Frischholz K; Haase KK; Geisler T; Zürn C; Hartmann U; Wöhrle J; Nusser T; Dippon J; May AE; Gawaz M
    Circ Cardiovasc Interv; 2009 Aug; 2(4):294-301. PubMed ID: 20031731
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions.
    Moses JW; Weisz G; Mishkel G; Caputo R; O'shaughnessey C; Wong SC; Fischell TA; Mooney M; Williams DO; Popma JJ; Fitzgerald P; Smith S; Kuntz RE; Collins M; Cohen SA; Leon MB
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):505-12. PubMed ID: 17896408
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Association between 1019C/T polymorphism of Connexin 37 gene and restenosis after coronary stenting].
    Yang Y; Guo SX; Yang ZY; Zhang T; Cao HM; Wang RX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Aug; 30(4):456-60. PubMed ID: 23926016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.